AzTrials
AzTrials

Cystic FibrosisVRAPNCT02802839

Virtual Reality for the Reduction of Pain During Venipuncture in Children With CF

A study testing Virtual Reality in people with Cystic Fibrosis, run by University of Florence at 1 site in Italy.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Children with Cystic fibrosis (CF) have to undergo several needle-related procedures during outpatient visits or hospital stay. It is common for children with CF to display distress and behavioural problems during invasive procedures. Read more about this study

Who is it for?
Ages 6 to 18 years
Conditions the study is for
Cystic Fibrosis
What is being tested?
Virtual Reality
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
50 participants
Where
1 siteItaly
Study dates
Jun 2016to Jun 2017
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 6 to 18 years
  • All sexes
  • No healthy volunteers
  • Child, Adult

Who may be able to join

  • CF diagnosed by at least two sweat test according to Gibson and Cook (Legrys 1996)
  • age from 6 to 18
  • regularly attending the CF centre of Florence
  • who do not wear glasses, do not have amblyopia, who do not have monocular vision
  • who have not taken pain medications in the last 8 hours
  • child's and parent's assent of the informed consent

Who cannot join

  • CF not diagnosed not diagnosed according to Gibson and Cook
  • under the age of 6 years and over the age of 18
  • not regularly attending the CF centre of Florence
  • who wear glasses, who have amblyopia, who have a monocular vision
  • who have taken pain medications in the last 8 hours
  • child's or parent's dissent of the informed consent

Trial locations and contacts

1 site in 1 country.

Sofia Bisogni, BSN, PhD contact

sofia.bisogni@unifi.it

Stella Neri, RN,BSN contact

sneri197@gmail.com

Italy1 site, 1 recruiting
  • Meyer Children Hospital

    Florence, 50139

    Filippo Festini, Prof of Nurs, 39 3472108993, filippo.festini@unifi.it

    Sofia Bisogni, RN MSN PhD

    Recruiting

Other trials in Italy

About this study

Official title: The Use of Virtual Reality in the Reduction of Pain and Anxiety During Venipuncture in Children With Cystic Fibrosis: a Randomized Controlled Trial

Children with Cystic fibrosis (CF) have to undergo several needle-related procedures during outpatient visits or hospital stay. It is common for children with CF to display distress and behavioural problems during invasive procedures. Children with chronic diseases have a lower threshold of pain compared to non-chronic patients. Effective management of needle distress in children with CF is critical. Although pharmacological and non pharmacological methods are used during needle -related procedures to lower painful stimuli nearly all patients with CF experience anxiety. Distraction has been shown to be an effective technique that directs children's attention away from noxious stimuli. The application of Virtual Reality (VR) in the medical field has been shown to be successful already 15 years ago. VR has found its use during the medication of burns and in patients undergoing cancer treatments whereas so far few studies have been published to assess its efficacy in reducing needle related pain and distress in children and none in children with CF.

Objectives To assess the efficacy of VR in reducing pain and distress during venipuncture in children with CF compared to routine care.

Read more

Project description Randomized controlled parallel trial with a 1 to 1 allocation ratio. The use of VR compared to standard care during venipuncture in children with CF (age 6-18 years) attending the outpatient clinic of the CF Centre of Florence will be compared over the period of 1 year. Patients randomly assigned to arm A will use VR during the procedure, those patients assigned to arm B will receive routine care.

Anticipated output Determination of the efficacy of VR in lowering pain and distress during venipuncture.

Read the detailed description

Research Plan: Background, Specific Aims and Rationale Background Cystic fibrosis (CF), the most common lethal genetic disorder in Caucasians, affects over 80,000 patients worldwide. Its incidence is calculated as occurring in one out of every 2,500 living newborns. Advances in the care of CF patients have been associated with impressive increases in survival during the last 30 years. The mean life expectancy for patients now diagnosed by newborn screening approaches 40 years and approximately 47% of Italian patients are 18 years of age or older. This striking result is mainly due to better treatment of bacterial lung infections, the main cause of pulmonary deterioration and early death of the patients. To be efficacious early diagnose and treatment are of fundamental importance this is why patients are routinely visited and tested several times during the year. Tests include also the collection of blood samples to detect and monitor infections and general health conditions. This means that after the diagnose of CF, children undergo at least 1 blood sample per year among other sample collections as sputum or throat swabs. Antibiotic intravenous treatment is not uncommon in these patients and involves the positioning of peripheral venous catheters (pvc), midlines or central venous access. As shown in previous studies it is common for children with CF to display distress and behavioural problems during invasive procedures. Like other children with chronic diseases children with CF have a lower threshold of pain compared to non-chronic patients as shown by data published by this research group. In fact there is a common belief among nurses and healthcare professionals that children, subject to repeated procedures, feel less pain because of a higher pain threshold compared to children who only sporadically visit the hospital. This misconception may lead professionals to lower their attention for the prevention and treatment of pain in children with chronic diseases. The purpose of the study of Bisogni was to compare the pain perceived and the behavioural distress shown during a standardized venipuncture by children with chronic diseases who have already been exposed to venipuncture, with those of a group of children who have never had any previous experience of venipuncture before. The results show that chronic children reported a median pain score of 8 on the Wong numeric scale, while non-chronic children reported a median pain score of 2. The results were statistically significant indicating that children subject to continue venipuncture procedures have a lower pain threshold than children of the same sex and age who experience venipuncture for the first time. This findings show that in daily clinical practice it is always necessary to promote effective and validated techniques to support patients for the reduction of pain and distress especially in chronic children who will need lifelong treatments and where anticipatory distress is very common. In fact nearly all patients with CF experience anticipatory pain. Anticipatory anxiety may be explained as a condition which precedes an event or an action where one thinks of the painful experience even before the actual painful stimuli occur. This leads children to live with high concern and fear the periodic hospital visits leading them to react in fight, flight or freeze mode and with their acute stress response affecting also parents and nurses behaviour. Different pharmacological and non pharmacological methods are already widely used during needle related procedures to try to lower pain and distress.

Specific Aims and Rationale The primary aim of this study is to assess the efficacy of VR as a distraction technique during the procedure of venipuncture for blood tests in children with CF in regards to anticipatory distress and pain. The parent ratings of their child's fear and pain and the nurse ratings of children's distress and cooperation will also be assessed.

Distraction has been shown to be an effective non pharmacological technique and is often defined as a strategy-whether cognitive or behavioral- that draws a child's attention away from noxious pain stimuli. Kleiber and Harper draw further distinctions and define distraction as a cognitive coping strategy that passively redirects the subject's attention or actively involves the subject with a task. Despite its widespread use, "there is no universally accepted theory to explain the function of distraction".

VR puts the patient in a different dimension allowing him to immerge into a different dimension shutting out what is going on around him. Patients will be able to choose among an age appropriate choice of VR apps. VR is believed to hold an advantage over other distraction techniques by virtue of its cocoon-like equipment and its engaging and immersive nature. Set in an enclosed headset, VR provides the opportunity for a mental escape by strategically drawing individuals into an alternative world. By controlling their perceptual environment, patients can redirect multiple senses from a hospital environment to one involving positive and entertaining activities.

The application of VR in the medical field has been shown to be successful already 15 years ago. VR has found its use during the medication of burns and in patients undergoing cancer treatments whereas so far few studies have been published to assess its efficacy in reducing needle related pain and distress in children and none in children with CF.

Koller in her review concludes that VR is a complex and costly method that holds promise as an effective intervention. However today the costs of such devices are more affordable starting from 6 euro for a cardboard device and up to 80 Euro for more sophisticated headsets, making this technique easily implemented. Several authors have called for larger sample sizes and more heterogeneous participants to determine how VR can be used most effectively.

Conditions
Cystic Fibrosis
Being tested
Virtual Reality
Keywords
Virtual Reality, venipuncture
Medical subject headings
Cystic Fibrosis

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT02802839
Study groupRoleWhat they receive
SperimentalExperimentalThe patient will be shown the headset for VR and a selection of age appropriate virtual realities to immerge in by the nurse not performing the procedure. There will be two lists of VRs to choose from, one for age 6 to 12 and one for age 12 to 18 with the following themes: amusement rides /carousel, space rides, zoo, safari, dinosaurs, city touring, landscapes, caverns. Once the patient is ready to wear the headset the application will start and 120 seconds later the procedure will take place. The nurse performing venipuncture will be a different one than the one handling distraction. Once the procedure ends the video will last for one more minute or up to the child' s desire. Only the first venipuncture attempt will be observed.
Receives: Device: Virtual Reality
ObservationalNo interventionControl intervention When arriving to the CF centre for routine visit that implies also the taking of blood samples, after having obtained the informed consent, a trained nurse of the CF Centre, will apply to each child recruited -in the presence of the parent, who may hold the child- the anesthetic cream. Only the first venipuncture attempt will be observed.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Pain

    Vas-Pain scale self administered by the patient and the parent

    Measured: 30 seconds after the procedure

Secondary outcomes (2)
  1. Anxiety

    Anxiety VAS consists of a 10-cm horizontal line, anchored on the left by the words ''not at all anxious'' and on the right by ''extremely anxious.'' A higher score indicates greater anxiety (Daveya 2007).

    Measured: before the procedure

  2. Distress

    The m-YPAS Scale is an observational scale that includes five categories of child behavior, giving them a score based on the descriptions provided in the same scale. These behaviors are: Activity (score 1 to 4), Vocalizations (score 1 to 6), Emotional Expressivity (score 1 to 4), State of Apparent Arousal (score 1 to 4), Use of Parents (score 1 to 4). The overall score is calculated by weighing the scores: the score of each category is divided by the number of items in the category. Then, the 5 calculated values in each category are added together and the sum is multiplied by 100 and divided by 5.

    Measured: during the procedure

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted16 Jun 2016 (estimated)
  2. Study startJun 2016
  3. Primary completionJun 2017 (estimated)
  4. Study completionJun 2017 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
50 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02802839
Sponsor's protocol ID
vers 1 del 15.02.16
Acronym
VRAP
Status last verified
Jun 2016
First submitted
6 Jun 2016
Last updated
16 Jun 2016
Results posted
No
Data monitoring committee
No
Individual data sharing
No

Publications

  • Duff AJ. Psychological interventions in cystic fibrosis and asthma. Paediatr Respir Rev. 2001 Dec;2(4):350-7. doi: 10.1053/prrv.2001.0171.

    PubMed 12052307
  • Bisogni S, Dini C, Olivini N, Ciofi D, Giusti F, Caprilli S, Gonzalez Lopez JR, Festini F. Perception of venipuncture pain in children suffering from chronic diseases. BMC Res Notes. 2014 Oct 18;7:735. doi: 10.1186/1756-0500-7-735.

    PubMed 25326685
  • Ayers S, Muller I, Mahoney L, Seddon P. Understanding needle-related distress in children with cystic fibrosis. Br J Health Psychol. 2011 May;16(Pt 2):329-43. doi: 10.1348/135910710X506895. Epub 2011 Mar 9.

    PubMed 21489060
  • Sermet-Gaudelus I, De Villartay P, de Dreuzy P, Clairicia M, Vrielynck S, Canoui P, Kirszenbaum M, Singh-Mali I, Agrario L, Salort M, Charron B, Dusser D, Lenoir G, Hubert D. Pain in children and adults with cystic fibrosis: a comparative study. J Pain Symptom Manage. 2009 Aug;38(2):281-90. doi: 10.1016/j.jpainsymman.2008.08.009. Epub 2009 Apr 11.

    PubMed 19364632
  • Gold JI, Kim SH, Kant AJ, Joseph MH, Rizzo AS. Effectiveness of virtual reality for pediatric pain distraction during i.v. placement. Cyberpsychol Behav. 2006 Apr;9(2):207-12. doi: 10.1089/cpb.2006.9.207.

    PubMed 16640481

Questions about this trial

What is this clinical trial studying?

A study testing Virtual Reality in people with Cystic Fibrosis, run by University of Florence at 1 site in Italy.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 16 Jun 2016. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Italy. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Sofia Bisogni, BSN, PhD (sofia.bisogni@unifi.it), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Pain (time frame: 30 seconds after the procedure). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02802839, which also lists 5 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Jun 2016.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in